Advertisement
Screener

PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) Net Cash Provided by (Used in) Investing Activities, Continuing Operations

2.0 / 5 stars · 19/47 Roast Me

PROVECTUS BIOPHARMACEUTICALS, INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations

PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$30.40 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-23.

Discontinued › Cash Flow › Investing Activities

us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2018-03-23

  • PROVECTUS BIOPHARMACEUTICALS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-12-31 was -$4.76K.
  • PROVECTUS BIOPHARMACEUTICALS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2015-12-31 was $0.00.
  • PROVECTUS BIOPHARMACEUTICALS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2015-09-30 was -$6.14K.
  • PROVECTUS BIOPHARMACEUTICALS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2015-06-30 was $0.00.
  • PROVECTUS BIOPHARMACEUTICALS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2017 was -$30.40K.
  • PROVECTUS BIOPHARMACEUTICALS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$6.14K.
  • PROVECTUS BIOPHARMACEUTICALS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$70.59K.
  • PROVECTUS BIOPHARMACEUTICALS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2013 was -$6.65K.
Period endNet Cash Provided by (Used in) Investing Activities, Continuing Operations 3 monthNet Cash Provided by (Used in) Investing Activities, Continuing Operations 6 monthNet Cash Provided by (Used in) Investing Activities, Continuing Operations 9 monthNet Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month
2017-12-31-$4.76K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-23
-$30.40K
10-K · filed 2018-03-23
2017-09-30-$25.64K
10-Q · filed 2017-11-08
2015-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31
-$6.14K
derived: sum of 2 quarters · filed 2017-03-31
-$6.14K
derived: sum of 3 quarters · filed 2017-03-31
-$6.14K
10-K · filed 2017-03-31
2015-09-30-$6.14K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09
-$6.14K
derived: sum of 2 quarters · filed 2016-11-09
-$6.14K
10-Q · filed 2016-11-09
-$6.14K
derived: sum of 4 quarters · filed 2017-03-31
2015-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06
$0.00
10-Q · filed 2015-08-06
$0.00
derived: sum of 3 quarters · filed 2017-03-31
-$70.59K
derived: sum of 4 quarters · filed 2017-03-31
2015-03-31$0.00
10-Q · filed 2015-05-07
$0.00
derived: sum of 2 quarters · filed 2017-03-31
-$70.59K
derived: sum of 3 quarters · filed 2017-03-31
-$70.59K
derived: sum of 4 quarters · filed 2017-03-31
2014-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31
-$70.59K
derived: sum of 2 quarters · filed 2017-03-31
-$70.59K
derived: sum of 3 quarters · filed 2017-03-31
-$70.59K
10-K · filed 2017-03-31
2014-09-30-$70.59K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05
-$70.59K
derived: sum of 2 quarters · filed 2015-11-05
-$70.59K
10-Q · filed 2015-11-05
-$70.59K
derived: sum of 4 quarters · filed 2016-03-30
2014-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06
$0.00
10-Q · filed 2015-08-06
$0.00
derived: sum of 3 quarters · filed 2016-03-30
2014-03-31$0.00
10-Q · filed 2015-05-07
$0.00
derived: sum of 2 quarters · filed 2016-03-30
2013-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30
-$6.65K
10-K · filed 2016-03-30
2013-09-30-$6.65K
10-Q · filed 2014-11-06